BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2938403)

  • 21. Humoral immunity in type 1 diabetes mellitus: a prospective study.
    Borsey DQ; Di Mario U; Irvine WJ; Gray RS; Guy K; Weston J; Peutherer J; Duncan LJ
    J Clin Lab Immunol; 1983 May; 11(1):9-15. PubMed ID: 6876143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An enzyme-linked immunoassay for detection of IgG- and C3-containing circulating immune complexes: comparison with a radioimmunoassay and quantitation in patients with rheumatic diseases.
    Panush RS; Somberg LB; Katz P; Longley S
    Diagn Immunol; 1983; 1(4):288-94. PubMed ID: 6388973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of elastin-antielastin circulating immune complexes (CIC) in diabetic patients with vascular damage.
    Baydanoff S; Nicoloff G; Russev T; Alexiev C
    Cor Vasa; 1988; 30(5):361-7. PubMed ID: 3229119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating immune complexes among diabetic children.
    Nicoloff G; Blazhev A; Petrova C; Christova P
    Clin Dev Immunol; 2004 Mar; 11(1):61-6. PubMed ID: 15154614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating immune complexes, insulin antibodies, and deposits of immunoglobulins in the skin in diabetes.
    Josephsen PG; Permin H; Juhl F; Enk B; Svehag SE
    Dan Med Bull; 1986 Jun; 33(3):171-4. PubMed ID: 3720367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of neutrophil activity and circulating immune complexes levels in diabetic patients.
    Inés Barañao R; Garberi JC; Tesone PA; Rumi LS
    Horm Metab Res; 1987 Aug; 19(8):371-4. PubMed ID: 3666672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immune complexes in diabetes mellitus].
    Kocić R; Radenković S; Milenović M; Mijailović M; Koraćević G; Zivić S; Pesić M; Kosić G
    Srp Arh Celok Lek; 1994; 122 Suppl 1():60-3. PubMed ID: 18173190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Participation of immune mechanisms in the development of microangiopathies in patients with non-insulin-dependent diabetes mellitus].
    Saltykov BB; Velikov VK; Shubina OI; Frolova AI; Pershin BB
    Arkh Patol; 1986; 48(5):16-21. PubMed ID: 3741172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Circulating immune complex and complement (C3) in a course of pulmonary tuberculosis].
    Dubaniewicz A; Sztaba-Kania M
    Pol Merkur Lekarski; 2002 Jun; 12(72):491-5. PubMed ID: 12362668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating immune complexes in patients with diabetes mellitus.
    Abrass CK; Heber D; Lieberman J
    Clin Exp Immunol; 1983 Apr; 52(1):164-72. PubMed ID: 6305541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quantitative changes of the blood serum immunoglobulins in patients with diabetes mellitus types I and II and microangiopathy detected by morphologic study].
    Saltykov BB; Velikov VK; Tarasov VK; Pershin BB; Kuz'min SN; Shubina OI; Frolova AI; Zelenchuk NM; Shepkova TP
    Ter Arkh; 1990; 62(4):111-4. PubMed ID: 2392748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a single numerical expression for the results of multiple screening tests for immune complexes in diabetic patients: use in statistical comparison of clinically and biochemically defined patient populations.
    Kilpatrick JM; Virella G
    J Clin Lab Immunol; 1982 Apr; 7(3):163-6. PubMed ID: 7047741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies to albumin in the plasma of patients with diabetes mellitus. Relationship with circulating immune complexes.
    Triolo G; Giardina E; Rinaldi A; Seddio G; Bompiani GD
    J Clin Lab Immunol; 1986 Nov; 21(3):113-5. PubMed ID: 3560190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum fibrillin-antifibrillin immune complexes among diabetic children.
    Nicoloff G; Angelova M; Nikolov A
    Vascul Pharmacol; 2005 Sep; 43(3):171-5. PubMed ID: 16095978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunological aspects of diabetic angiopathies pathogenesis].
    Galenok VA; Zhuk EA
    Ter Arkh; 1998; 70(10):5-10. PubMed ID: 9864794
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoglobulin isotypes in the circulating immune complexes of diabetic rats with and without proteinuria: a chronological study.
    Thiele GM; McDonald TL
    J Clin Lab Immunol; 1987 Jan; 22(1):19-28. PubMed ID: 3104596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
    Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
    Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the presence of circulating immune complexes in serum and C3b and C3d on red cells of kala-azar patients.
    Kharazmi A; Rezai HR; Fani M; Behforouz NC
    Trans R Soc Trop Med Hyg; 1982; 76(6):793-6. PubMed ID: 6761907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunomorphological study of diabetic microangiopathy].
    Saltykov BB; Velikov VK
    Arkh Patol; 2000; 62(2):5-9. PubMed ID: 10789005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.